TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: neuropsychological battery
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: LVT formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: acute procedural pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent on gaming
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BSCS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urethrocutaneous fistulae occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: clinical status distribution on day 11
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anxiety score on day 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scale (VAS) - back pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return to unrestricted full-time work
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: decrease of inflammatory acne lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Total and intact GDF‐15 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Yeast reduction of the genus Candida
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: 72-hour cumulative opioid consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FAOS Ache
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uncorrected visual acuity (UCCA) equal to 20/40 or better after six months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean increase of fundamental frequency (fo)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of aortic segmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Anteroposterior knee stability (KT-1000)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentile widening (%) of femoral and tibial tunnel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numerical pain scale (visual analog scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of secondary procedures
Endpoint domain: Adverse events/effects
Primary endpoint: Total operative room time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Improvement in musculoskeletal knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in physical exam skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean colony forming unit (CFU) count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Physical functioning scores (PhS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Psychosocial and mental scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Advance directive documentation in EHR
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Decision-maker documentation in EHR
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Readiness to engage in ACP
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Disability of Arm, Shoulder, and Hand scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Active ROM of the wrist flexion‐extension arc
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recent testing rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lifetime testing rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of ART initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative lung lesion remission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Clarity of MG secretions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of MGs yielding clear or cloudy liquid secretions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total MG secretion score in lower eyelid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return to Work (RTW) speed
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Chance of relapse
Endpoint domain: Adverse events/effects
Primary endpoint: Change in HF HRV during TSST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: aEEG scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: NBNA scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Isolation rate of RT-PCR-positive samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Co-culture delays
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary Sodium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coverage of alcohol measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive score on the Positive and Negative Syndrome Scale (PANSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ED use at 12 months
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Reduction in DU145 growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of PSI (Post-Surgical Infection)
Endpoint domain: Adverse events/effects
Primary endpoint: Leukopenia relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reduction of opioid use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dental service utilisation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: First compensatory step performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUROC value for prediction model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for CAB+RPV long-acting
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: adverse psychosocial development
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mental illness diagnosis
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Compliance with recommendations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite of end‐stage kidney disease, doubling of serum creatinine level, or renal or cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: depression severity categories
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: organ support-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: biofilm accumulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reassurance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of chest pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: isometric MVCF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Median dose-adjusted sertraline concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interindividual variation in maternal concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse effects on infants
Endpoint domain: Adverse events/effects
Primary endpoint: Total FSFI score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life changes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: IUGR index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: 1-y LDL cholesterol changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Confirmed Partial Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: stroke or systemic embolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of mineralized tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound healing index scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of MRI for small gaps (<3 mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of fluid volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact of intraretinal fluid on vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: months of compliance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: advanced neoplasia detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Sexual knowledge acquisition
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Positive sexual attitudes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sexual self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: BM-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Pulmonary functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isometric strength decrement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0−∞ of atorvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0−∞ of sofosbuvir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systematic changes in the importance of reported themes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean intra-operative blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: eGFR slope increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: reduction in urinary protein-creatinine ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Improvement of FEV1/FVC ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to proficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken to recruit a PCP
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost per recruited PCP
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: fewer anxiety symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: report at least one depressive symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: report symptoms of PTSD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: absence of most bothersome symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cytokine and inflammatory marker levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Responder rate by PR-SRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Undercarboxylated osteocalcin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bone mineral density (aBMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trait anxiety score reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: six-month mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: Rate of local recurrences
Endpoint domain: Adverse events/effects
Primary endpoint: number of biopsies with pain intensity of ≥4
Endpoint domain: Adverse events/effects
Primary endpoint: cases developing hematuria
Endpoint domain: Adverse events/effects
Primary endpoint: Time to extrication completion (tEX)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PREV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TceMEP amplitudes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cardiogenic shock
Endpoint domain: Adverse events/effects
Primary endpoint: Chances of achieving remission
Endpoint domain: Mortality/survival
Primary endpoint: appearance-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: maladaptive appearance-related beliefs
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Antioxidant capacity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lipid and lipoprotein profile alteration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sarcopenia risk classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean without-fail rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: YYIE1 performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incremental treadmill test time to exhaustion (TTE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reductions in drinking quantity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants pain-free or nearly pain-free
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hair density improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HG ratio improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gingival Index (GI) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Satisfaction (PS) improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in functional remission
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Length of total stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: mean number of EVs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall survival rate over one year
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of venous thrombosis (VT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Complete SRF resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean foveal sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rates after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: total bilirubin reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: conjugated bilirubin reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: bile acid level reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of chronic postoperative pain
Endpoint domain: Adverse events/effects
Primary endpoint: 10MWT performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACR 20
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants with ≥50% reduction of mean 24-h IEF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma dectin-1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: cumulative incidence of all malaria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: cumulative incidence of locally acquired malaria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: reservoir exhaustion duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year Overall Survival (OS) estimate
Endpoint domain: Mortality/survival
Primary endpoint: Decrease in immune activation markers (CD4+HLADR+CD38+, CD8+HLADR+CD38+ cells)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Increase in Bifidobacterium abundances
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean change in percent atheroma volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean change in maximum lipid core burden index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean change in minimal fibrous cap thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Shear Bond Strength (SBS) value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PAED score <12 after first dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of keratinocyte cancer lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Fasting serum insulin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Risk difference estimate for adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum heart rate during Modified Bruce treadmill test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximum distance during Modified Bruce treadmill test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of perceived exertion (RPE) during Modified Bruce treadmill test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentrations of cellular adhesion molecules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: EMG onset time of the paretic hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CNV latency reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ARAT and UL-FMA scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Childbirth experience measured with CEQ2
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall childbirth experience assessed with VAS
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Superior displacement of the clavicle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average stiffness of the synthetic ligament
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ultimate load-to-failure of the synthetic ligament
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Acuity (VA) difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of T cell subsets (CD3+, CD4+, CD8+)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Levels of inflammatory factors (CRP, TNF-a, IFN-?, IL-6, IL-10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Absolute change in hs-troponin-I
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Major PM-injury
Endpoint domain: Adverse events/effects
Primary endpoint: Minor PM-injury
Endpoint domain: Adverse events/effects
Primary endpoint: Successful decannulation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year all-cause death rate
Endpoint domain: Mortality/survival
Primary endpoint: 1-year death or HF hospitalization rate
Endpoint domain: Mortality/survival
Primary endpoint: 1-year reinfarction rate
Endpoint domain: Mortality/survival
Primary endpoint: ≥20% IOP reduction versus baseline unmedicated IOP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: MPE resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital Anxiety and Depression Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of medical minor complications
Endpoint domain: Adverse events/effects
Primary endpoint: Time to initial sound processor activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to VR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: care ability of caregivers
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: V̇O2peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes